Loading...
XSHE
002433
Market cap28mUSD
Jul 04, Last price  
0.27CNY
Name

Guangdong Taiantang Pharmaceutical CoLtd

Chart & Performance

D1W1MN
P/E
—
P/S
0.50
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-0.17%
Rev. gr., 5y
-34.15%
Revenues
410m
-43.39%
000000000003,315,297,7454,013,155,2373,581,948,5832,264,174,816724,844,899410,361,348
Net income
0k
00000000000270,891,71596,093,93922,225,674000
CFO
0k
-100.00%
11,903,78121,506,23447,165,1380061,147,482000076,955,181108,271,087336,247,2150833,892,028222,189,2740
Dividend
Jul 17, 20200.0151 CNY/sh

Profile

Guangdong Taiantang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese patent medicines in China. It offers medicines in the forms of creams, ointments, tablets, capsules, pills, and solutions for the areas, including reproductive health, skin health, cardiovascular, cerebrovascular, dermatology, anti-inflammatory, and other areas, as well as acquires, cultivates, processes, and sells Chinese medicinal materials. The company was founded in 1995 and is headquartered in Shantou, China.
URL
http://www.tatonline.net/
IPO date
Jun 18, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
410,361
-43.39%
724,845
-67.99%
Cost of revenue
602,880
621,251
Unusual Expense (Income)
NOPBT
(192,518)
103,594
NOPBT Margin
14.29%
Operating Taxes
9,316
33,259
Tax Rate
32.10%
NOPAT
(201,835)
70,336
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,176,972
924,307
Long-term debt
149,621
5,027
Deferred revenue
28,810
37,277
Other long-term liabilities
535,339
893,833
Net debt
901,236
470,254
Cash flow
Cash from operating activities
222,189
CAPEX
Cash from investing activities
447,406
3,136
Cash from financing activities
FCF
3,119,709
1,025,084
Balance
Cash
122,800
42,589
Long term investments
302,558
416,491
Excess cash
404,840
422,838
Stockholders' equity
872,989
985,540
Invested Capital
1,806,815
5,118,814
ROIC
1.25%
ROCE
1.87%
EV
Common stock shares outstanding
767,391
766,773
Price
2.36
-46.00%
4.37
-41.42%
Market cap
1,811,043
-45.95%
3,350,799
-41.42%
EV
2,814,363
3,933,717
EBITDA
(85,697)
231,344
EV/EBITDA
17.00
Interest
195,858
105,275
Interest/NOPBT
101.62%